• Logo
  • SBMUJournals

The association between gut microbiota, cholesterol gallstones and colorectal cancer

Sama Rezasoltani, Amir Sadeghi, Ebrahim Radinnia, Ali Naseh, Zahra Gholamrezaei, Mehdi Azizmohammad Looha, Abbas Yadegar
112

Views

PDF

Abstract

Gut microbiota play critical roles in maintaining the human health in several aspects. Bile acids (BAs) are endogenous cholesterol-derived molecules that can be modified by the gut microbiota and act as signaling molecules in the regulation of host metabolic and physiology processes. Gut microbiota release many enzymes that are capable to perform considerable modifications on BAs such as bile salt hydrolases (BSH), 7?-dehydroxylase (CYP7A), and hydroxysteroid dehydrogenase (HSDH). These enzymatic roles can change in the gut microbiota composition, cause alteration in BAs profile and metabolism and even gallstone formation. Patients with 15 years of asymptomatic gallstone have increased risk for colorectal cancer (CRC), which may be related to altered gut microbiota, changes in bile metabolism, as well as cellular and molecular effects in the proximal colon. In gallstone-associated CRC patients, the association between consensus molecular subtypes of CRC should be clarified to identify if specific pathways are related.

Keywords: Gut microbiota, Cholesterol gallstones, Colorectal cancer.

(Please cite as: Rezasoltani S, Sadeghi A, Radinnia E, NasehA, Gholamrezaei Z, Looha A, et al. The association between gut microbiota, cholesterol gallstones and colorectal cancer. Gastroenterol Hepatol Bed Bench 2019;12(Suppl.1):S8-S13).


Keywords

Gut microbiota, Cholesterol gallstones, Colorectal cancer.

References

- Sommer F, Backhed F. The gut microbiota--masters of host development and physiology. Nat. Rev. Microbiol 2013; 11:227-238.

- Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol 2016; 14: e1002533.

- Rezasoltani S, Asadzadeh-Aghdaei H, ENazemalhosseini-Mojarad E, Dabiri H, Ghanbari R, Zali MR. Gut microbiota, epigenetic modification and colorectal cancer. Iran J Microbiol 2017; 9: 55–63.

- Rostami Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of infectious mediators and gut microbiome inthe pathogenesis of celiac disease. Arch Iran Med 2015; 18:244-9.

- Rezasoltani S,Dabiri H, Asadzadeh-Aghdaei H, Akhavan Sepahi A, Modarressi MH. Nazemalhosseini-Mojarad E. The gut microflora assay in patients with colorectal cancer: in feces or tissue samples? Iran J Microbiol. 2019; 11: 1-6.

- Wu H, Tremaroli V, Backhed F: Linking Microbiota to Human Diseases: A Systems Biology Perspective. TEM. 2015; 26:758-770.

- Joyce SA, Gahan CG. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol. 2014; 30:120-127.

- Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018; 57: 1–24.

- Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489: 242-249.

- Clemente JC, Ursell LK, Parfrey LW, and Knight R. The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell. 201; 148:1258–1270.

- Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota, Gut Microbes. 2012; 3: 203–220.

- Rezasoltani S, Nazemalhosseini Mojarrad E, Norouzinia M, Asadzadeh Aghdaei H. The necessity of gut microbiome characterization in diseases prevention and therapy, Gastroenterol Hepatol Bed Bench. 2017;10:150-151.

- Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc. Natl. Acad.Sci. USA. 2005; 102:11070–11075.

- Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu. Rev Pathol. 2012; 7: 99–122.

- Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009; 1: 6ra14.

- Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE. 2009; 4:e7125.

- Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J. 2008; 2: 716–727.

- Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA.NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2001; 145: 745–757.

- Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 2000; 22: 283–297.

- Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science (New York, NY). 2012; 336:1262-1267.

- Arrieta MC, Finlay BB. The commensal microbiota drives immune homeostasis. Front Immunol.2012; 3:33.

- Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol. 2007; 19:59-69.

- Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol. 2009 Jan;10(1):83-91.

- Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011; 23: 255-264, e119.

- Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011; 108: 3047-52.

- Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Bäckhed F, Ohlsson C. The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012 Jun;27:1357-67.

- Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, Nielsen J, Ley RE, Backhed F. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut. 2012; 61:1124-1131.

- Martin AM, Sun1 EW, Geraint B. Rogers GB, Keating DJ.The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release. Front Physiol 2019; 10: 428.

- Reshetnyak VI. Physiological and molecular biochemical mechanisms of bile formation. World J Gastroenterol 2013; 19: 7341–7360.

- Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010; 90:859-904.

- Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999; 159: 2647–2658.

- Lorenzo-Zúñiga V, Bartolí R, Planas R, Hofmann AF, Viñado B, Hagey LR, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 2003 Mar;37(3):551-7.

- Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gutmicrobiome. Proc Natl Acad Sci USA 2008; 105: 13580– 13585.

- Stremmel W, Hofmann AF. Intestinal absorption of unconjugated dihydroxy bile acids: non-mediation by the carrier system involved in long chain fatty acid absorption. Lipids 1999; 25: 11–16.

- Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517: 205–208.

- Saltykova IV, Petrov VA, Logacheva MD, Ivanova PG, Merzlikin NV, Sazonov AE, et al. Biliary Microbiota, Gallstone Disease and Infection with Opisthorchis felineus. PLoS Negl Trop Dis. 2016; 10: e0004809

- Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014; 12:661–72

- Tabibian JH, Varghese C, LaRusso NF, O'Hara SP. The Enteric Microbiome in Hepatobiliary Health and Disease. Liver Int 2016; 36: 480–487.

- Verdier J, Luedde T, Sellge G. Biliary Mucosal Barrier and Microbiome. Viszeralmedizin 2015; 31:156-61

- Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 2006; 47:241-259.

- Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl. Acad. Sci. U.S.A 2008; 105; 13580-13585.

- Wells JE, Berr F, Thomas LA, Dowling RH, Hylemon PB. Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients. J. Hepatol 2000, 32: 4-10.

- Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014; 146:1525-1533.

- Skalhegg BA. On the 3 alpha-hydroxysteroid dehydrogenase from Pseudomonas testosteroni. Purification and properties. Eur J Biochem 1974; 46:117-125.

- Søreide K. Gallstone Disease and Cancer Risk: Finding the Bug in the System. Gastroentrology 2017; 152: 1825–1828.

- Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 7: 132–140.

- Chiong C, Cox MR, Eslick GD. Gallstones are associated with colonic adenoma: a meta-analysis. World J Surg. 2012; 36:2202–2209.

- Liang Q, Chiu J, Chen Y, et al. Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer. Clin Cancer Res. 2017; 23:2061–2070.

- Rezasoltani S, Sharafkhah M, Asadzadeh Aghdaei H, Nazemalhosseini Mojarad E, Dabiri H, et al. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods. 2018; 155:82-88.




DOI: https://doi.org/10.22037/ghfbb.v12i0.1823